Chief Financial Officer

Vice President Business Development

OX40 Targeted Therapy Clinical Trials Anti OX40 Antibody Development Market Opportunity Insight 2026

Hedge Funds Sit Out IPO Revival Despite Billion-Dollar Quarter

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

iKena Oncology appoints Yarema as CEO of ImageneBio

Associate Director / Director, Program & Regulatory Manager

ImageneBio is a biotech company focused on advancing therapeutic candidates. The Associate Director / Director, Program & Regulatory Management will lead cross-functional program execution and regulatory project management, ensuring the successful advancement of clinical-stage programs.

Sign up with Google

Sign in with Google